Pancreatic Cancer Research

ResearcherArmy Medical UniversityNo recent work listed

Bing Ni

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4297-5346; OpenAlex author ID A5053483219. Sources: OpenAlex.

Their work

Papers
14 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
36
Papers, trials and grants by year

2014: 2 papers · 2015: none · 2016: 1 paper · 2017: 2 papers · 2018: 1 paper · 2019: 1 paper · 2020: 4 papers · 2021: 1 paper · 2022: none · 2023: 2 papers

Papers 14

  1. Molecular subtypes based on cuproptosis-related genes and tumor microenvironment infiltration characteristics in pancreatic adenocarcinoma. Last author DOI 10.1186/s12935-022-02836-z↗
  2. Development and validation of a novel ferroptosis‑related lncRNA prognostic signature for pancreatic adenocarcinoma. Co-author DOI 10.3892/mmr.2023.12943↗
  3. N6-methyladenosine (m6A) in pancreatic cancer: Regulatory mechanisms and future direction. Last author DOI 10.7150/ijbs.60115↗
  4. ILC3 cells promote the proliferation and invasion of pancreatic cancer cells through IL-22/AKT signaling. Co-author DOI 10.1007/s12094-019-02160-5↗
  5. Upregulated GDF-15 expression facilitates pancreatic ductal adenocarcinoma progression through orphan receptor GFRAL. Co-author DOI 10.18632/aging.103830↗
  6. Establishing and validating a pathway prognostic signature in pancreatic cancer based on miRNA and mRNA sets using GSVA. Co-author DOI 10.18632/aging.103965↗
  7. Alteration of tumor-associated macrophage subtypes mediated by KRT6A in pancreatic ductal adenocarcinoma. Co-author DOI 10.18632/aging.104091↗
  8. Prognostic Values of CD38+CD101+PD1+CD8+ T Cells in Pancreatic Cancer. Last author DOI 10.1080/08820139.2019.1566356↗
  9. Doublecortin-Like Kinase 1 (DCLK1) Regulates B Cell-Specific Moloney Murine Leukemia Virus Insertion Site 1 (Bmi-1) and is Associated with Metastasis and Progn… Co-author DOI 10.1159/000495228↗
  10. Increased semaphorin 3c expression promotes tumor growth and metastasis in pancreatic ductal adenocarcinoma by activating the ERK1/2 signaling pathway. Co-author DOI 10.1016/j.canlet.2017.03.014↗
  11. Lin28B facilitates the progression and metastasis of pancreatic ductal adenocarcinoma. Co-author DOI 10.18632/oncotarget.19578↗
  12. Downregulated miR-506 expression facilitates pancreatic cancer progression and chemoresistance via SPHK1/Akt/NF-κB signaling. Co-author DOI 10.1038/onc.2016.90↗
  13. Increased intratumoral interleukin 22 levels and frequencies of interleukin 22-producing CD4+ T cells correlate with pancreatic cancer progression. Co-author DOI 10.1097/mpa.0000000000000055↗
  14. An increased abundance of tumor-infiltrating regulatory T cells is correlated with the progression and prognosis of pancreatic ductal adenocarcinoma. Co-author DOI 10.1371/journal.pone.0091551↗

Closest collaborators

The 25 strongest of 36 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Huaizhi Wang · 12 shared papers, 2014–2023 · strength 1.36
  2. Wenhua Li · 3 shared papers, 2018–2023 · strength 0.55
  3. Yongkang Liu · 3 shared papers, 2018–2023 · strength 0.48
  4. Jian Li · 3 shared papers, 2017–2023 · strength 0.48
  5. Zhiping Zhao · 6 shared papers, 2016–2020 · strength 0.47
  6. Shixiang Guo · 6 shared papers, 2014–2020 · strength 0.38
  7. Songsong Liu · 4 shared papers, 2017–2020 · strength 0.30
  8. Jian Li · 2 shared papers, 2017–2023 · strength 0.30
  9. Jingyang Yin · 1 shared paper, 2023 · strength 0.24
  10. Huan Qin · 3 shared papers, 2017–2020 · strength 0.23
  11. Mengjie Zhang · 2 shared papers, 2019–2020 · strength 0.22
  12. Jianyou Gu · 2 shared papers, 2020 · strength 0.20
  13. Junfeng Zhang · 2 shared papers, 2020 · strength 0.20
  14. Jiayun Ge · 2 shared papers, 2018–2020 · strength 0.17
  15. Yunchao Wang · 2 shared papers, 2017–2018 · strength 0.13
  16. Xiuyun Xuan · 1 shared paper, 2020 · strength 0.11
  17. Jianxun Jim Song · 1 shared paper, 2020 · strength 0.11
  18. Wenjing Yang · 1 shared paper, 2020 · strength 0.11
  19. Yongsheng Ouyang · 2 shared papers, 2016–2017 · strength 0.11
  20. Xianxing Wang · 1 shared paper, 2020 · strength 0.11
  21. Yingfang Fan · 1 shared paper, 2020 · strength 0.11
  22. Hui Sun · 1 shared paper, 2020 · strength 0.10
  23. Xuejun Xu · 2 shared papers, 2014 · strength 0.09
  24. Jian Li · 1 shared paper, 2018 · strength 0.07
  25. Yu You · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.